... "The moment I received my official diagnosis, I dropped all my assumptions about HIV. It was so freeing." -Member of myHIVteamLiving with a chronic condition can be difficult and even a burden, but also an opportunity to rid yourself of what you think you know. Have you heard the saying, "People don't get it until they get it"? ...
Beginner's Mind - Not Knowing It All When Living with HIV
... "The moment I received my official diagnosis, I dropped all my assumptions about HIV. It was so freeing." -Member of myHIVteamLiving with a chronic condition can be difficult and even a burden, but also an opportunity to rid yourself of what you think you know. Have you heard the saying, "People don't get it until they get it"? ...
... Does your doctor closely monitor your blood pressure? Share in the comments below. ...
... — HIV.gov HIV-1 and HIV-2 — Aidsmap HIV-2 Infection — StatPearls HIV-1 Subtypes — Aidsmap Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV — Clinicalinfo.HIV.gov HIV/AIDS — Mayo Clinic HIV-2 as a Model To Identify a Functional HIV Cure — AIDS Research and Therapy Plasma Viral Load in HIV-1 and HIV-2 Singly and Dually ...
HIV-1 vs. HIV-2: What Are The Differences and Can You Have Both?
... — HIV.gov HIV-1 and HIV-2 — Aidsmap HIV-2 Infection — StatPearls HIV-1 Subtypes — Aidsmap Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV — Clinicalinfo.HIV.gov HIV/AIDS — Mayo Clinic HIV-2 as a Model To Identify a Functional HIV Cure — AIDS Research and Therapy Plasma Viral Load in HIV-1 and HIV-2 Singly and Dually ...
... References Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention: A Randomized Trial — Annals of Internal Medicine Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention — Reprivetrial.org Having Three or More Metabolic Risk Factors ...
Preventing Diabetes With HIV: Study Reveals 4 Early Risks
... References Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention: A Randomized Trial — Annals of Internal Medicine Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention — Reprivetrial.org Having Three or More Metabolic Risk Factors ...
... Some ART regimens can affect blood sugar, so it’s crucial for your health care provider to monitor this if you’re taking GLP-1 drugs. These checks can often be added to your routine visits.Like any medication, GLP-1 drugs bring some potential risks. ...
GLP-1 Drugs and HIV: Is It Safe To Take Them With Your Meds?
... Some ART regimens can affect blood sugar, so it’s crucial for your health care provider to monitor this if you’re taking GLP-1 drugs. These checks can often be added to your routine visits.Like any medication, GLP-1 drugs bring some potential risks. ...
... It’s generally recommended that all individuals aged 15 and older be tested for HIV at least once in their lifetime. ...
... References HIV/AIDS Glossary: Antiretroviral (ARV) — Clinicalinfo.HIV.gov Antiretroviral Therapy — Cleveland Clinic Reverse Transcriptase Inhibitors — StatPearls How NRTIs Work — International Association of Providers of AIDS Care Emtricitabine — StatPearls A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate Versus Tenofovir ...
Emtricitabine and Tenofovir Combination for HIV: How It Works and More
... References HIV/AIDS Glossary: Antiretroviral (ARV) — Clinicalinfo.HIV.gov Antiretroviral Therapy — Cleveland Clinic Reverse Transcriptase Inhibitors — StatPearls How NRTIs Work — International Association of Providers of AIDS Care Emtricitabine — StatPearls A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate Versus Tenofovir ...
... — HIV.gov Head-to-Head Comparison of Accuracy of a Rapid Point-of-Care HIV Test With Oral Versus Whole-Blood Specimens: A Systematic Review and Meta-Analysis — Database of Abstracts of Reviews of Effects (DARE) ...